INTS

INTENSITY THERAPEUTICS, INC. INTS

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$4.79M total
Kingsbury Capital Investment Advisors LLC
$2.04M+1204.7%
KMT WEALTH MANAGEMENT, LLC
$2.04MNew
Sentinus, LLC
$109.6K+14.7%
VANGUARD CAPITAL MANAGEMENT LLC
$108.9K+57.8%
SAPIENT CAPITAL LLC
$106.6K0.0%
NANO CAP NEW MILLENNIUM GROWTH FUND L P
$102.5K0.0%
GEODE CAPITAL MANAGEMENT, LLC
$93.4K-12.4%
FNY Investment Advisers, LLC
$90.0KNew
Mesirow Financial Investment Management, Inc.
$57.9K0.0%
VANGUARD FIDUCIARY TRUST CO
$37.4K0.0%
Tower Research Capital LLC (TRC)
$8.1K+2861.2%
NewEdge Advisors, LLC
$4.7KNew
OSAIC HOLDINGS, INC.
$8200.0%
BARCLAYS PLC
$172New
MORGAN STANLEY
$820.0%
Caitong International Asset Management Co., Ltd
$25New
UBS Group AG
$4-99.5%
See all 17 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/INTS

Earnings Per Share

13fpro.ai/company/INTS

Loading ratio trend…

INTS insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About INTENSITY THERAPEUTICS, INC. (INTS): stock profile, AI score and financials

INTENSITY THERAPEUTICS, INC. (INTS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. INTS is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of INTS by reported 13-F value include Kingsbury Capital Investment Advisors, KMT WEALTH MANAGEMENT, Sentinus, based on the most recent SEC filings. INTS trades on the Nasdaq exchange and files with the SEC under CIK 1567264. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate INTS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for INTENSITY THERAPEUTICS, INC. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1567264 →